• Health Care

SMS Pharmaceuticals Limited receives non-exclusive license to manufacture and supply of nirmatrelvir (an oral COVID-19 medicine) through the Medicine Patent Pool (MPP)

New Delhi, March 20, 2022: SMS Pharmaceuticals Limited has received a non‐exclusive license through the Medicines Patent Pool (MPP) to…